These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 238705

  • 1. Combined alpha- and beta-adrenoceptor blocking drug AH 5158: further studies on alpha-adrenoceptor blockade in anaesthetized animals.
    Kennedy I, Levy GP.
    Br J Pharmacol; 1975 Apr; 53(4):585-92. PubMed ID: 238705
    [Abstract] [Full Text] [Related]

  • 2. Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.
    Farmer JB, Kennedy I, Levy GP, Marshall RJ.
    Br J Pharmacol; 1972 Aug; 45(4):660-75. PubMed ID: 4404413
    [Abstract] [Full Text] [Related]

  • 3. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT, Levy GP.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [Abstract] [Full Text] [Related]

  • 4. Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties.
    Elliott HL, McLean K, Meredith PA, Sumner DJ, Reid JL.
    Br J Clin Pharmacol; 1984 May; 17(5):565-72. PubMed ID: 6145440
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The alpha- and beta-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers.
    Riva E, Mennini T, Latini R.
    Br J Pharmacol; 1991 Dec; 104(4):823-8. PubMed ID: 1687367
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacology of combined alpha-beta-blockade. I.
    Louis WJ, McNeil JJ, Drummer OH.
    Drugs; 1984 Dec; 28 Suppl 2():16-34. PubMed ID: 6151889
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent.
    Miyagishi A, Nakahara H, Hara Y.
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):249-62. PubMed ID: 6210068
    [Abstract] [Full Text] [Related]

  • 14. Effect of labetalol on the uptake of [3H]-(-)-noradrenaline into the isolated vas deferens of the rat.
    Drew GM, Hilditch A, Levy GP.
    Br J Pharmacol; 1978 Jul; 63(3):471-4. PubMed ID: 667491
    [Abstract] [Full Text] [Related]

  • 15. [Interactions between alpha 1, alpha 2 and beta receptors in the blood pressure effects of adrenaline and noradrenaline in the dog].
    Mouillé P, Dabiré H, Joly G, Schmitt H.
    J Pharmacol; 1983 Jul; 14(3):325-32. PubMed ID: 6138461
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The relationships between the cardiovascular effects, alpha- and beta-adrenoceptor blocking actions and plasma concentration of labetalol in doca hypertensive rats.
    Drew GM, Hilditch A, Levy GP.
    Clin Exp Hypertens (1978); 1979 Jul; 1(5):597-611. PubMed ID: 42517
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.